Researcher

Fei Yan

Wuhan Sixth Hospital

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

GV21 enables ultrasound molecular imaging of tumor cell-associated VEGFR2 for early therapy assessment

Materials Today Bio

First-in-concept preclinical development of a novel imaging agent with no clinical efficacy or safety data, surrogate endpoint (imaging signal), and no controlled comparison of therapeutic outcomes.

PreliminaryFei Yan Liang Yang Xiaoxin Liang

Reported

GV21 particle size211.74 ± 1.05 nm

AUG 10, 2026 · JOURNAL ARTICLE

InflammatorySerum Olink Proteomics in Cancer-RelatedPain Treated with Opioids: A Pilot Cross-Sectional and LongitudinalStudy

Journal of Proteome Research

This is a small pilot cross-sectional and longitudinal study with a single-arm design and no randomized control, identifying protein signatures and post-hoc mechanistic associations that require confirmatory evidence in an independent cohort.

PreliminaryFei Yan Jie Deng Zihui Li

Reported

Nomogram AUC (five-protein signat…0.902

CRP AUC (comparator)0.625

Sample size44